Tirzepatide works gradually, and appetite suppression can come and go at first, particularly at lower doses
Heres the process: The injection must be part of a comprehensive treatment plan for a covered stay in the facility
A total of 10 participants (7.0%) were receiving the 3 mg dose, which is substantially lower than observed in IGNITE, in which 3 mg was received by 37% of participants [20]
Instead, the anesthesiologist should make recommendations on a case-by-case basis, and most patients do not need to stop taking the medication at all
A gradual taper supervised by a professional helps your body slowly adjust, making the return of hunger far more manageable
In some cases, a person may also self-administer an intramuscular injection